Ignite Creation Date:
2024-05-05 @ 9:53 PM
Last Modification Date:
2024-10-26 @ 10:11 AM
Study NCT ID:
NCT00989586
Status:
COMPLETED
Last Update Posted:
2017-02-06
First Post:
2009-10-02
Brief Title:
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Sponsor:
Organization:
Ohio State University Comprehensive Cancer Center